REQUEST A DEMO
Total
USD $0.00
Search more companies

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tasly Pharmaceutical Group Co.,Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) is an enterprise located in China, with the main office in Tianjin. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 30, 1998. It currently has a total number of 10,958 (2024) employees. In 2025, the company reported a net sales revenue drop of 3.08%. There was a total growth of 2.43% in Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司)’s total assets over the same period. The net profit margin of Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) increased by 2.78% in 2025.

Headquarters
No. 2, Pujihe East Road, Beichen District, Tianjin (Tasly Modern Chinese Medicine City)
Tianjin; Tianjin; Postal Code: 300410

Contact Details: Purchase the Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report to view the information.

Website: http://www.taslypharma.com

Basic Information
Total Employees:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report to view the information.
Registered Capital:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report to view the information.
Incorporation Date:
April 30, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
28%
Purchase this report to view the information.
17.21%
Purchase this report to view the information.
5%
Purchase this report to view the information.
3.15%
Purchase this report to view the information.
0.99%
Subsidiaries
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
100%
Tasly Bio-Pharmaceutical Co., Ltd.
100%
Tianjin Tasly Modern Chinese Medicine Resources Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-3.08%
Total Operating Revenue
-0.45%
Operating Profit
25.94%
Net Profit/Loss for the Period
23.55%
Total Assets
2.43%
Total Equity
3.6%
Operating Profit Margin
3.79%
Net Profit Margin
2.78%
Return on Equity (ROE)
1.37%
Debt / Equity
2749%
Quick Ratio
564.86%
Cash Ratio
-0.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?